Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas. (Q46318697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

F. Susan Wong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Alexei Y Savinov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Dmitri V Rozanov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Vladislav S Golubkov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

8 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

27755-27758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944163%20AND%20SRC:MED&resulttype=core&format=json

Regulatory T cells and type 1 diabetes

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

beta-Cell death during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in brea

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Determination of matrix metalloproteinase activity using biotinylated gelatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506016200